{"cursor":"21636","size":15,"audio":[],"currentlang":"en","article":"\n{| class = \"wikitable\" style = \"float:right; font-size:85%; margin-left:15px\"\n|+ List of stems for monoclonal antibody nomenclature -\n! Prefix colspan = \"3\" | Target substem colspan = \"2\" | Source substem Stem\n|-\n! || old || new || meaning || || meaning ||\n|- rowspan=\"19\" | variable -anibi- || — || angiogenesis (inhibitor) -a- ||\n|rat rowspan=\"19\" | -mab - -ba(c)- || -b(a)- || bacterium -e- || hamster - -ci(r)-\n||| -c(i)- || circulatory system -i- || primate - -fung- || -f(u)- || fungus -o-\n||| mouse - -ki(n)- || -k(i)- || interleukin -u- || human - -les- || — ||\n|inflammatory lesions -xi- || chimeric (human/foreign) - -li(m)- || -l(i)- ||\n|immune system -zu- || humanized - -mul- || — || musculoskeletal system\n|-xizu-* || chimeric/humanized hybrid - -ne(u)(r)- || -n(e)-* || nervous system\n|rowspan=\"2\" | -axo- || rowspan=\"2\" | rat/mouse hybrid (see [[trifunctional\n|antibody]]) - -os- || -s(o)- || bone - -toxa- || -tox(a)- || toxin rowspan=\"9\"\n|colspan=\"2\" | - -co(l)- || rowspan=\"7\" | -t(u)- || colonic tumor - -go(t)- ||\n|testicular tumor - -go(v)- || ovarian tumor - -ma(r)- || mammary tumor - -me(l)-\n||| melanoma - -pr(o)- || prostate tumor - -tu(m)- || miscellaneous tumor - -vi(r)-\n||| -v(i)- || virus - colspan=\"7\" | * under discussion }\n\nThe 'nomenclature of monoclonal antibodies' is a naming scheme for assigning\ngeneric, or nonproprietary, names to monoclonal antibodies. An antibody is a\nprotein that is produced in B cells and used by the immune system of humans and\nother vertebrate animals to identify a specific foreign object like a bacterium\nor a virus. Monoclonal antibodies are those that were produced in identical\ncells, often artificially, and so share the same target object. They have a wide\nrange of applications including medical uses.\n\nThis naming scheme is used for both the World Health Organizationâs\nInternational Nonproprietary Names (INN) and the United\nStates Adopted Names (USAN) for pharmaceuticals. In\ngeneral, word stems are used to identify classes of drugs, in most cases placed\nword-finally. All monoclonal antibody names end with the stem -mab. Unlike most\nother pharmaceuticals, monoclonal antibody nomenclature uses different preceding\nword parts (morphemes) depending on structure and function. These are officially\ncalled substems and sometimes erroneously [[infix]]es, even by the USAN Council\nitself.\n","linknr":427,"url":"Nomenclature_of_monoclonal_antibodies","recorded":1362901832,"links":49,"instances":["cell_biology","medicine","99mtc_nofetumomab_merpentan"],"pdf":["http://www.who.int/medicines/services/inn/generalpoliciesmonoclonalantibodiesjan10.pdf","http://www.who.int/medicines/services/inn/generalpoliciesmonoclonalantibodiesjan10.pdf","http://www.who.int/medicines/services/inn/StemBook2009.pdf","http://www.who.int/medicines/services/inn/StemBook2009.pdf","http://whqlibdoc.who.int/hq/1997/WHO_PHARM_S_NOM_1570.pdf","http://whqlibdoc.who.int/hq/1997/WHO_PHARM_S_NOM_1570.pdf","http://www.who.int/medicines/publications/druginformation/issues/DrugInfo09_Vol23-3.pdf","http://www.who.int/medicines/publications/druginformation/issues/DrugInfo09_Vol23-3.pdf","http://whqlibdoc.who.int/druginfo/18_1_2004_INN90.pdf","http://whqlibdoc.who.int/druginfo/18_1_2004_INN90.pdf","http://whqlibdoc.who.int/druginfo/DRUG_INFO_15_2_2001_INN-85.pdf","http://whqlibdoc.who.int/druginfo/DRUG_INFO_15_2_2001_INN-85.pdf","http://whqlibdoc.who.int/druginfo/18_2_2004_INN91.pdf","http://whqlibdoc.who.int/druginfo/18_2_2004_INN91.pdf","http://www.who.int/medicines/services/inn/INN_2008_list60.pdf","http://www.who.int/medicines/services/inn/INN_2008_list60.pdf","http://www.ama-assn.org/ama1/pub/upload/mm/365/olaratumab.pdf","http://www.ama-assn.org/ama1/pub/upload/mm/365/olaratumab.pdf","http://www.ama-assn.org/ama1/pub/upload/mm/365/benralizumab.pdf","http://www.ama-assn.org/ama1/pub/upload/mm/365/benralizumab.pdf","http://whqlibdoc.who.int/druginfo/INN_2002_list48.pdf","http://whqlibdoc.who.int/druginfo/INN_2002_list48.pdf","http://apps.who.int/medicinedocs/pdf/s4894e/s4894e.pdf","http://apps.who.int/medicinedocs/pdf/s4894e/s4894e.pdf","http://www.ama-assn.org/ama1/pub/upload/mm/365/rozrolimupab.pdf"],"categories":["Monoclonal antibodies|","Chemical nomenclature"],"headings":["Components","History","Examples","See also","References"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/15px-Symbol_support_vote.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Antibody_IgG2.png/220px-Antibody_IgG2.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/magnify-clip.png","//upload.wikimedia.org/wikipedia/commons/thumb/2/22/Chimeric_and_humanized_antibodies_with_CDRs.svg/220px-Chimeric_and_humanized_antibodies_with_CDRs.svg.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/magnify-clip.png","//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/E_A_Behring.jpg/170px-E_A_Behring.jpg","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/magnify-clip.png","//bits.wikimedia.org/static-1.21wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["clone","cell_biology"],["clearance","medicine"],["technetium","99mtc_pintumomab"],["technetium","99mtc_nofetumomab_merpentan"]],"members":["clone","clearance","technetium"],"related":["Angiogenesis","Rat","Bacterium","Hamster","Circulatory_system","Primate","Fungus","Mouse","Interleukin","Human","Lesion","Chimeric_antibody","Immune_system","Humanized_antibody","Musculoskeletal_system","Nervous_system","Bone","Toxin","Colon_cancer","Testicular_cancer","Ovarian_tumor","Mammary_tumor","Melanoma","Prostate_cancer","Virus","Monoclonal_antibodies","Antibody","Protein","B_cell","Immune_system","Vertebrate","Bacterium","Virus","Clone_(cell_biology)","World_Health_Organization","International_Nonproprietary_Name","United_States_Adopted_Name","Word_stem","Morpheme","Variable_domain","Variable_domain","Protein_domain","Antigen_binding_fragment","Single-chain_variable_fragment","Fc_region","Antibody_mimetic","Chimeric_antibody","Humanized","Human","Complementarity_determining_region","Rat","Hamster","Primate","Clearance_(medicine)","Allergic_reaction","Amino_acid_sequence","Protein_engineering","Constant_region","Complementarity_determining_region","Basiliximab","Macaque","Gomiliximab","Tumor","Organ_system","Circulatory_system","Infectious_agent","Bacteria","Virus","Therapeutic","Prophylactic","Diagnostic","Immune_system","Lymphocyte","Musculoskeletal_system","Adalimumab","Golimumab","TNF_inhibitor","PEGylated","Polyethylene_glycol","Immunogenicity","Cytotoxic_agent","Drug_targeting","Monomethyl_auristatin_E","Glembatumumab_vedotin","Chelator","Radioisotope","Pendetide","Pentetic_acid","Capromab_pendetide","Indium-111","Emil_von_Behring","Kitasato_Shibasaburō","Diphtheria_toxin","Tetanus_toxin","Nobel_Prize_in_Physiology_or_Medicine","Paul_Ehrlich","German_language","Hybridoma_technology","Georges_Köhler","César_Milstein","Niels_Kaj_Jerne","Muromonab-CD3","Olaratumab","Antineoplastic","Benralizumab","Asthma","TNF_alpha","Abciximab","Platelet","Breast_cancer","Trastuzumab","Technetium_(99mTc)_pintumomab","Technetium_(99mTc)_nofetumomab_merpentan","Technetium-99m","Rozrolimupab","Polyclonal_antibodies","List_of_monoclonal_antibodies","Monoclonal_antibody_therapy"]}